Avience Biomedicals (NSE:AVIENCE) Construction In Progress: ₹113.7 Mil (As of Jan. 2026)


NSE:AVIENCE Avience Biomedicals Ltd NSE:AVIENCE
5 GF Score
Price ₹414.95
View Full Analysis

What is Avience Biomedicals Construction In Progress?

Avience Biomedicals NSE:AVIENCE 5 Construction In Progress is ₹113.7 Mil as of Jan. 2026. GuruFocus rates NSE:AVIENCE with a GF Score™ of 5/100.

Avience Biomedicals's quarterly construction in progress increased from Mar. 2024 (₹0.3 Mil) to Mar. 2025 (₹46.2 Mil) and increased from Mar. 2025 (₹46.2 Mil) to Jan. 2026 (₹113.7 Mil).

Avience Biomedicals's annual construction in progress increased from Mar. 2023 (₹0.0 Mil) to Mar. 2024 (₹0.3 Mil) and increased from Mar. 2024 (₹0.3 Mil) to Mar. 2025 (₹46.2 Mil).

Avience Biomedicals Construction In Progress Historical Data

* Premium members only.

The historical data trend for Avience Biomedicals's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Avience Biomedicals Construction In Progress Chart

Avience Biomedicals Annual Data
Trend Mar23 Mar24 Mar25
Construction In Progress
0.00 0.28 46.19

Avience Biomedicals Quarterly Data
Mar23 Mar24 Mar25 Jan26
Construction In Progress 0.00 0.28 46.19 113.68
NSE:AVIENCE
5GF Score
Avience Biomedicals Ltd NSE:AVIENCE
Construction In Progress is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Avience Biomedicals Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

What does a Construction In Progress of ₹113.7 Mil mean?
Avience Biomedicals (NSE:AVIENCE) has a Construction In Progress of ₹113.7 Mil as of Jan. 2026. Construction in Progress records the amount of construction work that is not complete. View historical data on Avience Biomedicals and its competitors.
Is Avience Biomedicals' Construction In Progress too high?
Avience Biomedicals' current Construction In Progress is ₹113.7 Mil. Overall, Avience Biomedicals has a GF Score™ of 5/100, reflecting its overall financial health beyond just this single metric.
How does Avience Biomedicals' Construction In Progress compare to ABT and SYK?
Avience Biomedicals' Construction In Progress of ₹113.7 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Construction In Progress for a Medical Devices & Instruments company?
A good Construction In Progress depends on the Medical Devices & Instruments industry context. However, Construction In Progress should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Construction In Progress mean?
A high Construction In Progress can signal that a stock is expensive relative to its fundamentals. Construction in Progress records the amount of construction work that is not complete. View historical data on Avience Biomedicals and its competitors. Avience Biomedicals's current Construction In Progress is ₹113.7 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Avience Biomedicals stock overvalued right now?
Avience Biomedicals (NSE:AVIENCE) has a current Construction In Progress of ₹113.7 Mil. The current Construction In Progress is ₹113.7 Mil. Avience Biomedicals' overall GF Score™ is 5/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Construction In Progress calculated?
Construction In Progress is calculated from a company's financial statements. For Avience Biomedicals (NSE:AVIENCE), the current Construction In Progress is ₹113.7 Mil as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Avience Biomedicals Business Description

Address C-11, Block-C, Community Centre, Unit No-2, 1st Floor, Janakpuri A-3, New Delhi, IND, 110058
Avience Biomedicals Ltd is a medical consumables company focused on the manufacturing of Vitro-Diagnostic (IVD) products and medical devices. Its product offerings include diagnostic solutions used for the detection of diseases, conditions, and infections across laboratory, healthcare, and home-use applications. The company operates in areas including molecular biotechnology, genomics, and diagnostic products, and also provides distribution services for medical technology products in India. Its revenue is generated from Manufactured Goods and Traded Goods and Services, which include the sale of Medical Devices and Consumables.
5GF Score

Get the complete analysis for NSE:AVIENCE

Construction In Progress is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹414.95
Price